Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by numerous analysts, with many highlighting its robust growth potential, especially in the Asian market and wealth management. The company has successfully increased its dividend yield, currently sitting at approximately 4-5%, while its price-to-earnings (PE) ratio remains attractive compared to peers in the banking sector. Analysts have noted concerns over potential earnings drops but maintain a long-term positive outlook, suggesting that MFC is suitable for income-focused investors. While many emphasize the reliability of MFC's dividend and its strong position in life insurance, there are mixed feelings regarding its growth prospects compared to other financial institutions. Overall, the sentiment leans towards MFC being a solid choice for those seeking steady income and moderate growth, but some experts advise caution regarding market volatility.

Consensus

Positive

Valuation

Fair Value

Similar

GWO

DON'T BUY

Going through a digestion period. They cut the dividend and issued new shares to raise a lot of money, which cheesed a lot of people off. Negative sentiment will take some time to wear off.

COMMENT

Have guided that normalized earnings would be $1.85 per share making it under 10X earnings for the next year. You have to be patient. Expecting a cloud will continue to hang over the stock for a while.

COMMENT

Didn't like the issue of 2.5 billion of new shares. Overly conservative in raising money and diluting existing shareholders. Great exposure to Asia, which is the main thing that differentiates it from their peers. Given the earnings outlook it's a great buy but will be in the penalty box until they start spending some of that money.

WAIT

On a current basis, it is kind of absolute dog. It will remedy itself. At the current time, Sun Life (SLF-T) is better with a 5% dividend versus 3.5% and a market cap that is 2/3 better shape. It might be nearing the bottom that way for a while.

WEAK BUY

It is the premier North American life insurance company. One of the attractions is the operation in the far east. They could benefit from distressed asset purchases. Variable annuity product makes them a leveraged play on the US market. If there is another big correction in the market, they are still very vulnerable.

TOP PICK

Sold half his position when they cut the dividend but at $18 it is trading under 10 X earnings. Great long-term business. Will probably make Asian acquisitions.

HOLD

Feels the worst is over for them but wouldn't add to a position. Trading close to BV. In the penalty box for a while.

BUY

Below $19 there is only upside to the name. SLF would be his pick.

TOP PICK

Stumbled on raising capital and what they had in their guaranteed products. Lots of capital and will make acquisitions. Better growth in lifecos than in banks going forward. Potential to earn $2.50-$3 a share 2 years out, which would put the stock into the mid-$30's.

HOLD

Cut the dividend and then followed up by issuing more shares creating a great deal of dilution. Management is trying to create a bulletproof balance sheet. Doesn't think they have entirely lost the potential upside in an improving market. 2.8% yield.

DON'T BUY

Large surprise equity issue recently, which has not been cleared yet, which is why the share price is trading under the issue price. Lifecos in Canada are going to be in a pretty tight trading range until there is some clarity on the new regulations.

COMMENT

Feels there is valuation support at these levels.

DON'T BUY

Not a big fan of this. Likes companies that do well in a tough environment and will do well going forward. Due to product mixes they were in a tough spot. Economy has challenges ahead and this would be one of the first that has to come back to the market again.

TOP PICK

If you are coming into it now, the balance sheet is that much better. Now they can go on and make acquisitions. They are one of the leaders in Asia. Cleaned up their balance sheet. They are still getting priced at levels that are somewhat irrational. Expects 30% return over the next two years.

DON'T BUY

Announcement of the new equity issue caught everybody by surprise and he thinks they will have a tough slog and they may have to reduce the price to get rid of the shares. Thinks the stock will be a dead issue for a while. Longer-term they have good assets. Prefers the banks.

Showing 1,546 to 1,560 of 2,279 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)